References
- Benet LZ, Galeazzi RL. Noncompartmental determination of the steady-state volume of distribution. Journal of Pharmaceutical Sciences. 1974; 68: 1071–1074
- Duckett CJ, Lindon JC, Walker H, Abou-Shakra F, Wilson ID, Nicholson JK. Metabolism of 3-chloro-4-fluoroaniline in rat using [14C]-radiolabelling, 19F-NMR spectroscopy, HPLC-MS/MS, HPLC-ICPMS and HPLC-NMR. Xenobiotica 2006; 36: 59–77
- Hazuda D, Felock P, Witmer M, Wolfe A, Stillmock K, Grobler JA, Espeseth A, Gabryelski L, Schleif W, Blau C. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 2000; 287: 646–650
- Hazuda DJ, Young SD, Guare JP, Anthony NJ, Gomez RP, Wai JS, Vacca JP, Handt L, Motzel SL, Klein HJ, et al. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques. Science 2004; 305: 528–532
- Lenz EM, Lindon JC, Nicholson JK, Weeks JM, Osborn D. 19F-NMR spectroscopic investigation into the absorption and metabolism of 3-trifluoromethylaniline, in Eisenia veneta. Ecotoxicology and Environmental Safety 2003; 54: 257–168
- Lindon JC. Fluorine nuclear magnetic resonance. Encyclopaedia of analytical science. Academic Press, London 1995; 3408
- Markowitz M. Potent antiretroviral effect of MK-0518, a novel HIV-1 integrase inhibitor, as part of combination ART in treatment-naïve HIV-1 infected patients. 16th International AIDS Conference, TorontoCanada, 2006
- Petrocchi A, Koch U, Matassa VG, Pacini B, Stillmock KA, Summa V. From dihydroxypyrimidine carboxylic acids to carboxamide HIV integrase inhibitors: SAR around the amide moiety. Bioorganic Medicine and Chemistry Letters 2006; 17: 350–353
- Ramirez M. Integrase inhibitor: MK-0518. 10th European AIDS Conference, DublinIreland, 2006, abst LPBS1/6
- Summa V, Gardelli C, Muraglia E, Nizi E, Orvieto F, Petrocchi A, Rowley M, Laufer R, Gonzalez Paz O, Monteagudo E. Discovery of RALTEGRAVIR formally MK-0518 a potent, selective oral bioavailable HIV-integrase inhibitors with potent antiviral efficacy in the clinic. Journal of Medical Chemistry (submitted) 2007
- Summa V, Petrocchi A, Matassa VG, Gardelli C, Muraglia E, Rowley M, Gonzalez Paz O, Laufer R, Monteagudo E, Pace P. 4,5-Dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV-1 integrase inhibitors with good pharmacokinetic profiles in preclinical species. Journal of Medical Chemistry 2006; 49: 6646–6649
- Wade KE, Wilson ID, Troke JA, Nicholson JK. 19F and 1H magnetic resonance strategies for metabolic studies on fluorinated xenobiotics: Application to flurbiprofen [2-(2-fluoro-4-biphenylyl)propionic acid]. Journal of Pharmacology and Biomedicine Analysis 1990; 8: 401–410
- Wilson ID, Nicholson JK. Solid phase extraction chromatography and NMR spectroscopy (SPEC-NMR) for the rapid identification of drug metabolites in urine. Journal of Pharmacology and Biomedicine Analysis 1988; 6: 151–165